Friday, February 27, 2026 | 08:18 AM ISTहिंदी में पढें
Page 2 - Morepen Laboratories
Morepen surges 18% on USFDA clearance for anti-asthmatic drug Montelukast
The stock surged 18% to Rs 29.60, also its 52-week high on NSE, after the pharmaceutical company announced that the USFDA has cleared anti-asthmatic drug, Montelukast Sodium.
 "Morepen surges 18% on USFDA clearance for anti-asthmatic drug Montelukast")
Updated On : 20 Dec 2017 | 11:14 AM IST
Morepen Laboratories soars on reports of likely sale of OTC brands
The stock hit a high of Rs 27.25 and a low of Rs 26.10 so far during the day
Updated On : 23 Sep 2016 | 10:23 AM IST
Morepen to go big on therapies for preventive cardiology & diabetology
To expand its services in the diagnostics and therapy segment in the coming years
Updated On : 21 Aug 2016 | 7:50 PM IST
Morepen set to go big on therapies for preventive cardiology, diabetology
Dr Morepen Now is also entering into a strategic partnership with Singapore-based Renew group to expand its centres few years from now
 "Morepen set to go big on therapies for preventive cardiology, diabetology")
Updated On : 21 Aug 2016 | 4:06 PM IST